论文部分内容阅读
据悉,江西新瑞丰生化有限公司研制开发的40%赤霉酸可溶粒剂新产品的最后一次大田试验在6月7日完成,并报请江西省工信委进行产品标准备案。该产品的成功研制,将为该企业拓展国内外赤霉酸制剂市场奠定基础。
It is reported that Jiangxi New Ruifeng Biochemical Co., Ltd. developed 40% of gibberellin soluble granules of the new product of the last field trial completed on June 7, and submitted to the Jiangxi Provincial Committee for product standards for the record. The successful development of this product will lay the foundation for the enterprise to expand the market of gibberellic acid at home and abroad.